Product Information
MEXILETINE 250 MG CAPSULE is a generic product labeled by Chartwell RX LLC, priced at $0.4464 per EA under NDC 62135078590. Its NADAC has been published 124 times since Feb 14, 2024.
The High Outlier badge above means this manufacturer's average price in the mexiletine hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
250 mg/1
Manufacturer
Chartwell RX LLCNDC
62135078590
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MEXILETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213500On Market Since
7/23/2020
Pharmacological Classes
Price Statistics
The NADAC for MEXILETINE 250 MG CAPSULE has been published 124 times since Feb 14, 2024, and over the history we have for it it has declined 57.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4464 per EA |
|---|---|
| All-time high | $1.0421 (Apr 10, 2024) |
| All-time low | $0.4101 (Nov 19, 2025) |
| 52-week high | $0.4943 |
| 52-week low | $0.4101 |
| Median price | $0.4649 |
| Average price | $0.5016 |
| Largest weekly change | -57.2% (Apr 17, 2024) |
| Weeks tracked | 124 |
| Tracking since | Feb 14, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MEXILETINE 250 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MEXILETINE 250 MG CAPSULE, manufactured by Chartwell RX LLC, is $0.4464 per EA (NDC 62135078590), effective Jun 24, 2026.
How has the price of MEXILETINE 250 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MEXILETINE 250 MG CAPSULE has declined 57.2%. It has been tracked across 124 weekly CMS publications since Feb 14, 2024.
What are the highest and lowest recorded NADAC prices for MEXILETINE 250 MG CAPSULE?
Since Feb 14, 2024, the NADAC for MEXILETINE 250 MG CAPSULE has ranged from a low of $0.4101 (Nov 19, 2025) to a high of $1.0421 (Apr 10, 2024), with a median of $0.4649 per EA.
Are there cheaper alternatives to MEXILETINE 250 MG CAPSULE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as MEXILETINE 250 MG CAPSULE, but none are currently priced below it.
Who manufactures MEXILETINE 250 MG CAPSULE?
MEXILETINE 250 MG CAPSULE (NDC 62135078590) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification